Watch Ticker

Anavex Life Sciences

Go to Anavex Life Sciences Website

$10.82

0.00 (0.00%)

Live

Previous Close

$10.82

Day Range

$0 - $0

Previous Day Range

$10.68 - $11.425

Market Cap

$956.7 million USD

Day Vol.

Previous Day Vol.

860167

Currency

USD

Primary Exchange

Nasdaq

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from cl...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - ANAVEX SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Long-Term Investors to Contact the Firm

Kaskela Law LLC is investigating potential breach of fiduciary duty claims against Anavex Life Sciences Corp. (AVXL) regarding the company's misleading statements about its Rett syndrome drug blarcamesine and the failure of its clinical trial.

Related tickers: AVXL.

Read Full Article

N/A - Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

Anavex Life Sciences announced positive long-term results from a Phase IIb/III trial of its drug blarcamesine for early Alzheimer's disease, showing continued clinical benefit and a favorable safety profile over up to 4 years of treatment.

Related tickers: AVXL.

Read Full Article

Trending Tickers

Please sign in to view